静脉注射免疫球蛋白治疗对复发性植入失败的影响:系统性审查和元分析
Parijot Kumar1, Chris E Philip2, Karine Eskandar3
1Rotunda Hospital, Dublin, Ireland.
Journal of reproductive immunology
|September 6, 2024
概括
在辅助生殖中,静脉注射免疫球蛋白 (IVIg) 可能会改善复发性植入失败 (RIF) 的妇女的活产率. 这一元分析表明IVIg增强了怀孕结果,特别是在选定的患者群体.
科学领域:
- 生殖医学和辅助生殖技术 (ART)
- 生殖中的免疫学.
- 临床试验分析
背景情况:
- 静脉注射免疫球蛋白 (IVIg) 用于自身免疫性疾病,但在辅助生殖方面面临怀疑.
- 关于IVIg用于复发性植入失败 (RIF) 的现有临床数据正在扩大,但需要更新证据评估.
- 需要进行系统性审查和元分析,以评估RIF患者接受ART的IVIg疗效.
研究的目的:
- 评估IVIg在改善辅助生殖技术 (ART) 后复发植入失败 (RIF) 患者的治疗结果方面的有效性.
- 综合来自随机对照试验和观察性研究的证据,比较IVIg治疗与 defined RIF人群中的安慰剂.
主要方法:
- 随机对照试验和观察性研究的系统审查和元分析.
- 在文献中搜索RIF在ART后使用预孕IVIg.IVIg.进行的研究.
- 分析主要结果:临床妊娠率 (CPR),活产率 (LBR),植入率 (IR) 和流产率 (MR) 来自12项研究 (1023例,2276对照).
主要成果:
- IVIg治疗显著增加了临床怀孕率 (OR=5.14) 和活产率 (OR=4.60).
- 植入率显著改善 (OR=2.35) 和流产率减少 (OR=0.60) 被观察到.
- 在研究中发现了大量的异质性,并通过子组分析加以解决.
结论:
- 在RIF患者中,IVIg可以提高植入,临床怀孕和活产率,为特定人群提供好处.
- 积极的免疫风险因素可以确定合适的候选人,但IVIg也可能有利于高档胚胎的不明原因的RIF.
- 在复杂的RIF病例中,个性化治疗策略对于改善ART结果至关重要.
相关概念视频
01:24In Vitro Fertilization
232
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
232
01:15Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493